These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 23174991)
1. Para-aminosalicylic acid plasma concentrations in children in comparison with adults after receiving a granular slow-release preparation. Liwa AC; Schaaf HS; Rosenkranz B; Seifart HI; Diacon AH; Donald PR J Trop Pediatr; 2013 Apr; 59(2):90-4. PubMed ID: 23174991 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance. Adams KT; Donald PR; Abulfathi AA; Diacon AH; Stander MA; Reuter H J Clin Pharmacol; 2020 Apr; 60(4):489-494. PubMed ID: 31682027 [TBL] [Abstract][Full Text] [Related]
4. Once-daily and twice-daily dosing of p-aminosalicylic acid granules. Peloquin CA; Berning SE; Huitt GA; Childs JM; Singleton MD; James GT Am J Respir Crit Care Med; 1999 Mar; 159(3):932-4. PubMed ID: 10051275 [TBL] [Abstract][Full Text] [Related]
5. Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosis. Kibleur Y; Brochart H; Schaaf HS; Diacon AH; Donald PR Clin Drug Investig; 2014 Apr; 34(4):269-76. PubMed ID: 24488376 [TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis. Sy SK; de Kock L; Diacon AH; Werely CJ; Xia H; Rosenkranz B; van der Merwe L; Donald PR Antimicrob Agents Chemother; 2015 Jul; 59(7):4129-38. PubMed ID: 25963985 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ethambutol in children and adults with tuberculosis. Zhu M; Burman WJ; Starke JR; Stambaugh JJ; Steiner P; Bulpitt AE; Ashkin D; Auclair B; Berning SE; Jelliffe RW; Jaresko GS; Peloquin CA Int J Tuberc Lung Dis; 2004 Nov; 8(11):1360-7. PubMed ID: 15581206 [TBL] [Abstract][Full Text] [Related]
9. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. McIlleron H; Willemse M; Werely CJ; Hussey GD; Schaaf HS; Smith PJ; Donald PR Clin Infect Dis; 2009 Jun; 48(11):1547-53. PubMed ID: 19392636 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis. van der Laan LE; Garcia-Prats AJ; Schaaf HS; Chirehwa M; Winckler JL; Mao J; Draper HR; Wiesner L; Norman J; McIlleron H; Donald PR; Hesseling AC; Denti P Antimicrob Agents Chemother; 2022 Jun; 66(6):e0226421. PubMed ID: 35506699 [TBL] [Abstract][Full Text] [Related]
11. Direct lung delivery of para-aminosalicylic acid by aerosol particles. Tsapis N; Bennett D; O'Driscoll K; Shea K; Lipp MM; Fu K; Clarke RW; Deaver D; Yamins D; Wright J; Peloquin CA; Weitz DA; Edwards DA Tuberculosis (Edinb); 2003; 83(6):379-85. PubMed ID: 14623169 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditions. Peloquin CA; Zhu M; Adam RD; Singleton MD; Nix DE Ann Pharmacother; 2001 Nov; 35(11):1332-8. PubMed ID: 11724078 [TBL] [Abstract][Full Text] [Related]
13. Para-aminosalicylic acid: the return of an old friend. Donald PR; Diacon AH Lancet Infect Dis; 2015 Sep; 15(9):1091-1099. PubMed ID: 26277036 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers. Park SI; Oh J; Jang K; Yoon J; Moon SJ; Park JS; Lee JH; Song J; Jang IJ; Yu KS; Chung JY Antimicrob Agents Chemother; 2015 Aug; 59(8):4429-35. PubMed ID: 25987620 [TBL] [Abstract][Full Text] [Related]
15. [Levels of free and acetylized PAS in the blood after the administration ALPAS]. Kostić M; Krajovan R Tuberkuloza; 1966; 18(5):469-76. PubMed ID: 16296053 [No Abstract] [Full Text] [Related]
16. Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens. Abulfathi AA; Assawasuwannakit P; Donald PR; Diacon AH; Reuter H; Svensson EM Eur J Clin Pharmacol; 2020 Nov; 76(11):1557-1565. PubMed ID: 32588106 [TBL] [Abstract][Full Text] [Related]
17. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children. Thee S; Detjen A; Quarcoo D; Wahn U; Magdorf K Int J Tuberc Lung Dis; 2007 Sep; 11(9):965-71. PubMed ID: 17705973 [TBL] [Abstract][Full Text] [Related]
18. Brain regional pharmacokinetics of p-aminosalicylic acid and its N-acetylated metabolite: effectiveness in chelating brain manganese. Hong L; Jiang W; Pan H; Jiang Y; Zeng S; Zheng W Drug Metab Dispos; 2011 Oct; 39(10):1904-9. PubMed ID: 21768272 [TBL] [Abstract][Full Text] [Related]
19. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline. Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis. Lee HW; Kim DW; Park JH; Kim SD; Lim MS; Phapale PB; Kim EH; Park SK; Yoon YR Int J Tuberc Lung Dis; 2009 Sep; 13(9):1161-6. PubMed ID: 19723408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]